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Background: The carcinoembryonic antigen (CEA)-related cell adhesion molecules CEACAM1 (BGP, CD66a),
CEACAM5 (CEA, CD66e) and CEACAM6 (NCA, CD66c) are expressed in human lung. They play a role in innate and
adaptive immunity and are targets for various bacterial and viral adhesins. Two pathogens that colonize the normally
sterile lower respiratory tract in patients with chronic obstructive pulmonary disease (COPD) are non-typable
Haemophilus influenzae (NTHI) and Moraxella catarrhalis. Both pathogens bind to CEACAMs and elicit a variety of
cellular reactions, including bacterial internalization, cell adhesion and apoptosis.
Methods: To analyze the (co-) expression of CEACAM1, CEACAM5 and CEACAM6 in different lung tissues with respect
to COPD, smoking status and granulocyte infiltration, immunohistochemically stained paraffin sections of 19 donors
were studied. To address short-term effects of cigarette smoke and acute inflammation, transcriptional regulation of
CEACAM5, CEACAM6 and different CEACAM1 isoforms by cigarette smoke extract, interferons, Toll-like receptor
agonists, and bacteria was tested in normal human bronchial epithelial (NHBE) cells by quantitative PCR.
Corresponding CEACAM protein levels were determined by flow cytometry.
Results: Immunohistochemical analysis of lung sections showed the most frequent and intense staining for CEACAM1,
CEACAM5 and CEACAM6 in bronchial and alveolar epithelium, but revealed no significant differences in connection
with COPD, smoking status and granulocyte infiltration. In NHBE cells, mRNA expression of CEACAM1 isoforms
CEACAM1-4L, CEACAM1-4S, CEACAM1-3L and CEACAM1-3S were up-regulated by interferons alpha, beta and gamma,
as well as the TLR3 agonist polyinosinic:polycytidylic acid (poly I:C). Interferon-gamma also increased CEACAM5
expression. These results were confirmed on protein level by FACS analysis. Importantly, also NTHI and M. catarrhalis
increased CEACAM1 mRNA levels. This effect was independent of the ability to bind to CEACAM1. The expression of
CEACAM6 was not affected by any treatment or bacterial infection.
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Conclusions: While we did not find a direct correlation between CEACAM1 expression and COPD, the COPD-associated
bacteria NTHi and M. catarrhalis were able to increase the expression of their own receptor on host cells. Further, the
data suggest a role for CEACAM1 and CEACAM5 in the phenomenon of increased host susceptibility to bacterial
infection upon viral challenge in the human respiratory tract.
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Polyinosinic:polycytidylic acid (poly I:C), Non-typable Haemophilus influenzae (NTHI), Moraxella catarrhalisBackground
CEACAMs are members of the immunoglobulin super-
family and are involved in the regulation of various cel-
lular functions such as differentiation, proliferation,
apoptosis and many more [1]. All CEA family members
are highly glycosylated and mediate homophilic and/or
heterophilic binding. CEACAM1 is found on epithelial
cells, endothelial cells and on leukocytes, including granu-
locytes, T cells, B cells, and NK cells [2-4]. CEACAM5 is
expressed on epithelial cells and CEACAM6 on granu-
locytes and epithelial cells [1]. Many CEACAMs can be
recruited by different pathogens as receptors and, in
addition to effectuate adhesion, mediate bacterial internal-
ization and even evasion of immune responses [3]. Patho-
gens interacting with members of the CEA family include
gram-negative bacteria colonizing human respiratory mu-
cosa, like Neisseria meningitidis, typable and non-typable
Haemophilus influenzae and Moraxella catarrhalis [5-11].
The ability of pathogens to target CEACAMs possibly al-
lows them to colonize mucosal surfaces by mediating ad-
hesion and by exploiting immunosuppressive functions of
CEACAM receptors. Pathogen binding to CEACAM1 is
of especial importance since it leads to the suppression of
several receptors that activate important cellular pathways
of the innate or adaptive immune response, such as Toll-
like receptor (TLR) 2, TLR4, T-cell receptor and B-cell
receptor [12-18]. The interferences with TLR signaling
as well as the interference with T-cell activation by
CEACAM1 depend on the phosphorylation of the
immuno-receptor tyrosine-based inhibitory motif (ITIM)
contained within the cytoplasmic domain of the long
CEACAM1 isoforms [15,16,19].
In human lung epithelia, three members of the CEA
protein family known to interact with pathogens are
found: CEACAM1, CEACAM5 and CEACAM6 [20-24].
CEACAM5 and CEACAM6 are glycosylphosphatidyli-
nositol (GPI)-anchored to the cell membrane and possess
seven and three extracellular Ig-like domains, respectively
[24]. The four most commonly co-expressed CEACAM1
isoforms, CEACAM1-4L, CEACAM1-3L, CEACAM1-4S
and CEACAM1-3S, possess three or four extracellular Ig-
like domains, a trans-membrane domain and a long or a
short intracellular domain [24]. While CEACAM1-L is
able to transmit signals via its ITIM, CEACAM1-S is stillable to mediate homophilic and heterophilic interac-
tions and can trigger actin cytoskeleton re-organization
[25,26]. CEACAM1-S can thus not only mediate adhe-
sion as well as internalization of pathogens [27], but
can also control the signaling activities of the long
CEACAM1 isoforms [28].
Chronic obstructive pulmonary disease (COPD) is a
major cause of morbidity and mortality and is expected
to be the third leading cause of death, and the fifth lea-
ding cause of disability by 2020 [29]. The Global Ini-
tiative for Chronic Obstructive Lung Disease defines
COPD as characterized by persistent airflow limitation
that is usually progressive and associated with an en-
hanced chronic inflammatory response in the airways
and the lung to noxious particles or gases. Exacerbations
are associated with increased airway and systemic in-
flammation, and evidence suggests that 70% may be
caused by microorganisms [30]. Two pathogens that are
associated with acute exacerbations and the progression
of COPD are the CEACAM-interacting pathogens M.
catarrhalis and H. influenzae, which often colonize the
mucosa of the lower human respiratory tract in patients
with COPD [31-33]. M. catarrhalis and H. influenzae
express structurally unrelated outer membrane proteins,
ubiquitous surface protein A1 (UspA1), and P5-
homologous adhesin (P5), respectively, that share the abil-
ity to bind to the extracellular immunoglobulin V (IgV)-
like domain of human CEACAM1 [5,8]. The interaction
of CEACAM1 with M. catarrhalis results in reduced
TLR2-initiated inflammatory responses of primary pul-
monary epithelial cells [16]. CEACAM5 and CEACAM6
can mediate bacterial adhesion as well [5,7,8,34]. All three
CEACAMs in human airway epithelia can therefore be of
importance for the colonization of the lower airways and
have a role in acute exacerbations. Since the lower respira-
tory airways are normally sterile and protected by
mucociliary clearance, CEACAMs expressed here are
most likely to encounter bacteria in medical conditions
leading to dysfunction of the mucociliary clearance, such
as COPD [35]. To date, a comprehensive analysis of (co-)
expression patterns of CEACAM1 isoforms, CEACAM5
and CEACAM6 in the different lung tissues is lacking.
In the present study, we found CEACAM1, CEACAM5,
and CEACAM6 expression on all pulmonary epithelia of
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terns were not dependent on COPD, smoking status and
granulocyte infiltration. In NHBE cells, CEACAM1 ex-
pression was enhanced upon exposure to interferons, the
TLR3 agonist polyinosinic:polycytidylic acid (poly I:C), M.
catarrhalis, and NTHi. However, there were no differences
in the induction of the different CEACAM1 isoforms
tested (CEACAM1-4L, CEACAM1-3L, CEACAM1-4S
and CEACAM1-3S). CEACAM5 expression was increased




All materials used were from Sigma or Merck unless
stated otherwise. Mouse monoclonal antibodies: B3-17
and C5-1X (both mono-specific anti-human CEACAM1,
B. B. Singer/Reliatech), 5C8C4 and 2H8-5 (both mono-
specific anti-human CEACAM5, B. B. Singer), 13H10 and
1H7-4B (both mono-specific anti-human CEACAM6,
Genovac and B.B. Singer), 6/40c (mono-specific anti-
human CEACAM8, B.B. Singer), and IgG1 isotype control
antibody (Antibodies-Online). Polyclonal antibodies: HRP-
coupled rabbit anti-mouse IgG (Dako), HRP-coupled goat
anti mouse IgG (Dianova), rabbit polyclonal anti-CEA IgG
(Dako), HRP-coupled goat anti-mouse IgG (Dianova),
Alexa Fluor 488-conjugated goat anti-mouse IgG (Life
Technologies), PE-conjugated goat anti-mouse IgG (H+L,
Antibodies-Online).
Acquisition and processing of human lung specimens
Tissue was obtained from surgical specimens, patients
underwent surgery for lung resection to treat lung can-
cer. A positive vote of the ethics committee of the Uni-
versity of Heidelberg and informed consents were
obtained. The resected tissue was fixed in formalin and
embedded in paraffin using standard procedures [36].
Immunohistochemical analysis
Immunohistochemical staining for CEACAM1, CEACAM5,
CEACAM6 and CEACAM8 using 20 μg/ml of the mono-
clonal antibodies B3-17, 5C8C4, 1H7-4B and 6/40c, re-
spectively, was performed on paraffin wax sections
obtained from 19 different human lung sections. Sections
were deparaffinized (Histoclear 3 × 5 min, ethanol 100% 5
min, ethanol 96% 5 min, ethanol 80% 5 min, ethanol 70%
5 min) and rehydrated (H2O 2 × 5 min). Rabbit serum-
blocking (2% in PBS) was performed before the sections
were incubated with primary antibody over night at 4°C,
and with HRP-coupled secondary rabbit antibody for 1 h
at RT. Then the nickel-glucose oxidase development tech-
nique was performed to enhance the DAB chromogen of
the peroxidase immunohistochemistry. The specimens
were counterstained with Calcium Red for 1–2 minutes tovisualize the tissue structure. The result was a distinct pur-
ple/black staining product. As negative control served an
IgG1 istotype matched control antibody. Non-cancer tis-
sues from the sections were used for analysis.
Acquisition of bronchoalveolar lavage fluid (BALF)
BALF samples were obtained from 181 individuals in
whom a bronchoscopy was performed for different diag-
nostic or therapeutic purposes. All individuals underwent
bronchoscopy following standard diagnostic procedures at
the department of infectious diseases and pulmonary
medicine at the Charité -Universitätsmedizin Berlin with
informed consents from the patients. The study was ap-
proved by the ethical committee of the Charité and all
samples were available as residual material without any per-
sonal information or clinical data. BALF was centrifuged at
1,200 rpm and supernatants were then collected and stored
in aliquots at −80°C until processing for ELISA.
CEACAM1-, CEACAM5-, and CEACAM6-specific
Sandwich-ELISA
Frozen BALF samples were thawed and centrifuged at
2000 × g and 4°C for 10 min. Then CEACAM1,
CEACAM5, and CEACAM6 were assessed in the super-
natants. 96 well micro titer plates (MaxiSorb TM plates,
Nunc) were coated for 2 h at room temperature with 3
μg/ml rabbit anti-CEA-antibody (Dako) diluted in PBS.
After washing the plate twice with 0.05% Tween (Carl
Roth GmbH) in PBS all unbound sites were blocked for
2 h at room temperature with PBS containing 3% bovine
serum albumin (Carl Roth GmbH). To quantify the dif-
ferent CEACAMs in the samples appropriate standard
curves were prepared by making serial dilutions of re-
combinant human CEACAM1-Fc, recombinant human
CEACAM6-Fc and purified CEA (from 0.25 ng/ml to
100 ng/ml). The standard and the undiluted samples were
incubated over night at 4°C and washed three times. Then
20 μg/ml C5-1X (anti-CEACAM1), 5C8C4 (CEACAM5),
or 1H7-4B (CEACAM6) were added. Plates were washed
three times with PBS and supplemented with HRP-
coupled goat anti mouse antibody (Dianova) for 2 h
followed by three washing steps. Then 100 μl TMB-X-tra
substrate (Biotrend Chemikalien GmbH) were added and
incubated for up to 30 min. The reaction was stopped by
20 μl of 2 N H2SO4 (Carl Roth) and optical densities were
read at 450 nm in a microplate reader (Tecan). All anti-
bodies, samples and standard curves were diluted in PBS
containing 1.5 % BSA. The linear ranges for CEACAMs 1,
5, and 6 were 0.25 ng/ml - 100 ng/ml.
Preparation of aqueous phase cigarette smoke extract (CSE)
CSE was prepared as described [37]. Briefly, smoke from
one cigarette (10 mg Tar, 0.8 mg nicotine; Camel Filters,
Japan Tobaco International) with the mouthpiece filter
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using a peristaltic pump (P-1, GE Healthcare) and fil-
tered through a 0.22 μm filter. Suction was regulated, so
that sidestream smoke developed during the entire com-
bustion, lasting 5 min for each cigarette. The filtered CSE
was regarded as 100%. CSE was used within 30 min of
preparation at a final concentration of 4%. Lau et al.
showed that NHBE cells were induced to secrete IL-8 and
remained viable after tratment with 4% CSE for 24 h [37].
Cell culture, treatments and infections
Primary normal human bronchial epithelial (NHBE) cells
(Lonza) were propagated as suggested by the supplier in
collagen I-coated flasks or plates (BD Biosciences) in
Bronchial Epithelial Cell Basal Medium (BEBM, Lonza)
supplemented with bovine pitituary extract (BPE),
Hydrocortisone, human Epidermal Growth Factor (hEGF)
Epinephrine, Transferrin, Insulin, Retinoic acid and Tri-
iodothyronine (from the BEGM bullet Kit, Lonza). Prior
to stimulation, cells in passage 4–6 were grown to conflu-
ence. NHBE cells were treated for the indicated durations
with 100 ng/ml IFNα (interferon alpha 1a, ImmunoTools),
100 ng/ml IFNβ (interferon beta 1a, ImmunoTools), 100
ng/ml IFNγ (recombinant human interferon gamma,
Promokine), 100 ng/ml TNFα (recombinant human
tumor necrosis factor alpha, R&D Systems), 100 ng/ml
MALP-2 (Enzo Life Sciences GmbH), 100 ng/ml poly I:C
(high molecular weight, InvivoGene), 100 ng/ml flagellin
(Invivogene Biotech), or 4% CSE (see above). The concen-
trations chosen for the treatments described above are
standard concentrations used for lung epithelial cells
[37-43]. Infections werde done using the following strains:
M. catarrhalis: 25238 (wild type, American Type Culture
Collection); BBH18 (wild type) and BBH18.1 (adhesin
UspA1 deletion mutant unable to bind CEACAM1), both
kindly provided by Kristian Riesbeck, Malmö Lund Uni-
versity, Skåne University Hospital, Malmö, Sweden; non-
typable Haemophilus influenzae (NTHi): 2019 (wild type),
kindly provided by Edward Swords, University of Iowa,
USA; 1128 (wild type) and 1128f- (adhesin P5 deletion
mutant unable to bind to CEACAM1), both kindly pro-
vided by Lauren O. Bakaletz, The Research Institute at
Nationwide Children’s Hospital and The Ohio State Uni-
versity College of Medicine, USA. For infection, bacteria
were freshly grown over night at 37°C, 5% CO2 on
Columbia Agar or Chocolate Agar, respectively (both BD
Biosciences). Bacteria were incubated to exponential
growth (mid-log phase) in liquid Brain Heart Infusion
(BHI) broth at 210 rpm, 37°C (BHI, BD Biosciences; for
NTHi supplemented with 10 μg/ml hemin, Sigma Aldrich,
and 10 μg/ml NAD, MP Biomedicals). Bacteria were
harvested by centrifugation and re-suspended in PBS.
Colony forming units (cfu) were determined by measure-
ment of optical densities (M. catarrhalis: OD405 nm = 0.3correlates with 5×107 cfu/ml; NTHi: OD600 nm = 0.1 corre-
lates with 108 cfu/ml). Cells were infected for 24 h at a
multiplicity of infection (MOI) of 5 (Moraxella catarrhalis)
or 100 (NTHi). Optimal MOIs were determined in pilot
experiments by analysis of maximal induction of inter-
leukin 8 secretion in the absence of cytotoxic effects
(data not shown).
Immunoprecipitations from cell culture supernatants
NHBE cell culture supernatants from confluent cells
were harvested after 48 h. CEACAM1, CEACAM5 and
CEACAM6 were precipitated from 10 ml supernatant
using 20 μl protein G-Sepharose 4 Fast Flow (GE
Healthcare) and 3 μg of monoclonal antibodies B3-17,
2H8-5, and 13H10, respectively. An IgG1 isotype control
was included. Immunoprecipitations were analyzed by
Western blot using anti CEA polyclonal antibody that
cross-reacts with all three CEACAMs and HRP-coupled
goat anti-rabbit IgG. Analysis was done using the Fusion
FX System (Peqlab) and SuperSignal West Pico Chemi-
luminescent Substrate (Thermo Scientific).
RT-PCR and qPCR analysis
To analyze the gene expression of CEACAM1, CEACAM5,
and CEACAM6, total RNA was extracted from 2×106
NHBE cells using the Qiagen RNeasy mini kit. Residual
genomic DNA was removed by on-column incubation
with DNaseI (Qiagen). A NanoDrop D-1000 Spectropho-
tometer (Thermo-Fisher Scientific) was then used to as-
sess the amount and quality of the isolated RNA samples.
First-strand complementary DNA (cDNA) was synthe-
sized from 2 μg of RNA using the High Capacity cDNA
Reverse Transcription Kit (Applied Biosystems). To detect
the expression of the CEACAM genes by PCR, specific
primers for each target were designed using the on-line
primer-BLAST tool of the National Center for Biotech-
nology Information (NCBI, http://www.ncbi.nlm.nih.gov/
tools/primer-blast/). Possible secondary structures at the
primer binding sites were taken into account by character-
izing the nucleotide sequence of the regions of interest
using the Mfold algorithm [44]. Primer design across dif-
ferent exon boundaries allowed for specific primer pairs
targeting 7 isoforms of CEACAM1. Primers were also
designed for CEACAM5, CEACAM6, two housekeeping
genes, and IFNβ-1a.
PCRs of the cDNAs were carried out on a S1000TM
Thermal Cycler (BioRad) in a 25 μl reaction volume
containing 0.2 μM primers, 1 U Taq DNA polymerase
(5-Prime) and 200 μM dNTPs. Thermal conditions in-
cluded an initial 95°C denaturation step for 3 min, and
then 35 cycles of 10 s at 94°C, 30 s at 60°C and 30 s at
72°C. The resulting PCR products were separated on an
ethidium bromide containing agarose gel and visualized
under a UV-transiluminator to confirm the expected





Chronic obstructive pulmonary disease (COPD) 8
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Granulocyte infiltration 9
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fragments of the CEACAM genes and the different spli-
cing variants of CEACAM1, PCR-products were purified
and sequenced (Eurofins MWG Operon, Ebersberg,
Germany). Sequences were aligned with the correspon-
ding NCBI-reference transcripts using ClustalX [45].
To quantify the relative expression of each gene, we used
a CAS-1200 pipetting robot (Qiagen) to set up the qPCR-
reactions and a Corbett Rotor-Gene 6000 (Qiagen) as
Real-Time qPCR apparatus. Each sample was analyzed in
duplicate in a total reaction volume of 20 μl containing 10
μl of 2× SensiMix SYBR Master Mix (Bioline) and 0.2 μM
of each primer. The cycling conditions included an initial
step of 95°C for 10 min followed by 40 cycles of 95°C for
15 s, 60°C for 20 s and 72°C for 20 s. For each experiment,
an RT-negative sample was included as a control. Melting
curve analysis and size verification by electrophoresis was
used to confirm the specificity of the qPCR reactions.
The relative expression of the target genes was ana-
lyzed using the Pfaffl method [46]. The expression levels
were normalized to the geometric mean of 2 house-
keeping genes: hypoxanthine phosphoribosyltransferase1
(HPRT1) and peptidylpropyl isomerase B (PPIB). The
stability of the housekeeping genes was assessed using
the BestKeeper algorithm [47]. Relative differences in
mRNA expression between different experimental condi-
tions were analyzed by pair-wise fixed randomization
tests using the REST 2009 software [48].
Confocal microscopy
NHBE cells were grown on cover slips, fixed in PBS/4%
paraformaldehyde and blocked with PBS/10% bovine
serum albumin. Confocal images of indirect immunofluo-
rescence of CEACAM1, CEACAM5 and CEACAM6 (B3-
17, 2H8-5, and 16H10, respectively, and Alexa Fluor
488-conjugated goat anti-mouse IgG), actin (TRIC-con-
jugated phalloidin) and nuclei (Hoechst33342) were taken
using a Zeiss 710 confocal microscope equipped with the
Plan-APO 40X/1.4 Oil objective. Pictures were processed
using the Zen Software (Zeiss) and Adobe Photoshop.
FACS analysis
NHBE cells were cultured and treated as described above,
detached using trypsin/EDTA (Invitrogen/Life Science)
and kept in PBS/2% FBS on ice. Cells were stained using
antibodies B3-17 (CEACAM1) and 2H8-5 (CEACAM5) at
10 μg/ml, and 1:200 PE-conjugated goat anti-mouse IgG.
Analysis was done using the FACSAria II (BD Biosciences)
and FlowJo (Tree Star Inc.) Software.
Results
CEACAM expression in human lung
Expression and co-expression patterns of CEACAM1,
CEACAM5 and CEACAM6 in the human lung wereanalyzed. Paraffin sections of lung tissues from 19 do-
nors who underwent surgery for lung resection to treat
lung cancer (Table 1) were stained with an IgG control
antibody and antibodies specific for CEACAM1, 5 and
6, as well as with an antibody specific for CEACAM8,
which is solely expressed in human granulocytes. Non-
cancer tissues from these sections were used for analysis.
Figure 1 shows representative CEACAM stainings of
lung sections for the respective antibodies. Table 2 gives
an overview of the number of positive tissues in the
specimens. CEACAM1 was expressed in 12 out of 19
lungs, CEACAM5 in 18 out of 19 and CEACAM6 in all
19 lungs examined (Figure 1 and Table 2). As expected,
granulocyte-specific CEACAM8 (Figure 1D, Table 2)
showed strong staining if infiltrated granulocytes appeared
(data not shown) and did not give any staining above IgG
background in granulocyte-free lung tissues (Table 2).
CEACAM1 expression was most intense in bronchial
epithelium, where it was found in 10 specimens out of
19 (Figure 1A, Table 2). Blood vessel endothelium also
showed distinct CEACAM1 staining (11/19). A weaker
expression was found in alveolar epithelium and pleura
(10/19 and 10/17 respectively). In some cases the adven-
titia submucosa was CEACAM1 positive (5/17).
CEACAM5 displayed frequent and intense staining in
bronchial and alveolar epithelium (Figure 1B, Table 2).
The former tissue was always positive when found in the
respective specimen (17/17), the latter in 16 out of 19
samples. Also, pleura and blood vessel endothelium were
often CEACAM5 positive (12/17 and 15/19, respect-
ively). A weaker and less frequent CEACAM5 expression
was found in the adventitia submucosa (11/17).
CEACAM6 showed an abundant and strong staining in
the alveolar epithelium of all lungs examined (Figure 1C,
Table 2). The bronchial epithelium of most specimens also
displayed a strong CEACAM6 expression (15/18). In some
cases, the pleura exhibited a weak CEACAM6 staining (6/
18). Adventitia submucosa and blood vessel endothelium
did not show any CEACAM6 expression.
CEACAM co-expression patterns in human lung tissues
The co-expression patterns of CEACAM1, CEACAM5
and CEACAM6 in the different lung tissues of the 19
















































Figure 1 Expression of CEA family members in human lung. Paraffin sections of human lung tissue from surgical specimens of lung cancer
patients were stained for (A) CEACAM1, (B) CEACAM5, (C) CEACAM6, (D) CEACAM8 and (E) IgG control antibody using indirect immune-peroxidase
technique. Note that blood cells give a positive signal due to intrinsic peroxidase activity. Non-cancer tissues were used for analysis. 1, alveolar
epithelium; 2, bronchial epithelium; 3, adventitia submucosa; 4, pleura; 5, pulmonary blood vessel endothelium. Original magnification 200X.
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epithelium, CEACAM6 was present in all specimens;
therefore, only CEACAM1 and CEACAM5 expressions
varied. CEACAM1 was mostly co-expressed with both,
CEACAM5 and CEACAM6. In bronchial epithelium,Table 2 Analysis of CEACAM expression in human lung sectio
Positive specimen * Alveolar epithelium Bronchial epit
Control IgG 3§/19 1/19 1/15
aCEACAM1 12/19 10/19 10/17
aCEACAM5 18/19 16/19 17/17
aCEACAM6 19/19 19/19 15/18
aCEACAM8 1§/19 1/19 0/16
Paraffin sections of human lung tissue from surgical specimens of lung cancer patie
unspecific control IgG.
Figure 1 shows representative pictures of non-cancer tissues for these stainings. CE
bronchial epithelium, adventitia submucosa, pleura and blood vessel endothelium.
specimen and the number of total specimen including the respective tissue are giv
epithelium, adventitia submucosa, pleura and blood vessel endothelium and exclud
showed enhanced background staining for the control IgG or the anti-CEACAM8 anCEACAM5 was expressed in all specimens; only
CEACAM1 and CEACAM6 expression varied. Both
proteins were co-expressed with CEACAM5 alone and
with each other. The adventitia submucosa was always
negative for CEACAM6. CEACAM1 and CEACAM5ns






nts (N=19) were stained for CEACAM1, CEACAM5, CEACAM6, CEACAM8 and an
ACAM expression in non-cancer tissues was analyzed for alveolar epithelium,
Since not all tissue types were found for all specimens, the number of positive
en. *Assessment of total staining includes alveolar epithelium, bronchial
es present blood cells due to intrinsic peroxidase activity. §Four lung sections
tibody.











CC1+/CC5+/CC6+ 12 8 7 - 3 -
CC1+/CC5+/CC6- - - 3 4 4 8
CC1+/CC5-/CC6- - - - 1 - 3
CC1-/CC5+/CC6+ 6 8 7 - 1 -
CC1-/CC5+/CC6- - - - 7 4 7
CC1-/CC5-/CC6- - - - 4 2 1
CC1-/CC5-/CC6+ - 1 - - - -
CC1+/CC5-/CC6+ 1 2 - - 1 -
No evaluation possible§ - - 2 2 4 -
Paraffin sections of human lung tissue from surgical specimens of lung cancer patients (N=19) were stained for CEACAM1, CEACAM5, and CEACAM6. Figure 1
shows representative pictures for these stainings. Non-cancer tissues were analyzed for the co-expression of CEACAM1, CEACAM5 and CEACAM6. Numbers of
specimens with the respective pattern denominated in column 1 are given. *Assessment of total staining includes alveolar epithelium, bronchial epithelium,
adventitia submucosa, pleura and blood vessel endothelium, and excludes present blood cells due to intrinsic peroxidase activity. §One or more stainings for
CEACAM1, CEACAM5 or CEACAM6 are missing for this tissue in a specimen preventing an evaluation.
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pleura was positive for CEACAM6, at least one of
the two other CEACAMs were co-expressed. Most of
the CEACAM6-negative specimens showed pleura
staining for CEACAM5, and some for CEACAM5
and CEACAM1. Blood vessel endothelium was negative
for CEACAM6 and showed staining for CEACAM1 and
CEACAM5 either alone or together (Table 3). Co-
expression patterns showed no correlation to COPD,
smoking status and granulocyte infiltration in total stain-
ing analysis or in the individual lung tissues (alveolar epi-
thelium, bronchial epithelium, adventitia submucosa,
pleura and blood vessel endothelium; data not shown).
CEACAM expression in human lung does not correlate
with COPD, smoking status or granulocyte infiltration
It was then examined whether the presence or expres-
sion level of CEACAM1, CEACAM5 and CEACAM6
were linked to COPD or smoking status. Table 4 shows
the relative staining intensity of the three CEACAMs.
Total staining of the paraffin sections, including alveolar
epithelium, bronchial epithelium, adventitia submucosa,
pleura and blood vessel endothelium, was assessed inTable 4 No association of CEACAM expression with pathologi
Leukocyte infiltration COPD
+ - + -
CEACAM1 0.67 (0.71) 1.00 (1.00) 1,13 (0.67) 0.47 (
CEACAM5 1.22 (0.67) 1.90 (1.00) 1.25 (0.92) 1.94 (
CEACAM6 2.44 (0.53) 2.70 (1.00) 2.50 (0.53) 2.82 (
CEACAM8 0.11 (0.33) 0.10 (0.77) 0.13 (0.32) 0
IgG control 0.11 (0.33) 0.20 (1.14) 0.25 (0.42) 0.06 (
Paraffin sections of human lung tissue from surgical specimens of lung cancer patie
unspecific control IgG. Figure 1 shows representative pictures for these stainings. R
adventitia submucosa, pleura and blood vessel endothelium) were assessed in the
intensity and standart deviation. No significant differences were found in comparisothe range of 0 (no staining) to 3 (strong staining).
However, no correlation was found for either the pres-
ence (data not shown) or the expression levels (Table 4)
of the tested CEACAMs according to two-tailed Stu-
dent’s t-test. Next, the interdependency of CEACAM1,
CEACAM5 and CEACAM6 expression with granulocyte
infiltration was analyzed, but again no correlation was
detected (Table 4). Also, the correlation of CEACAM
expression with COPD, smoking status and granulocyte
infiltration in the individual lung tissues (alveolar epithe-
lium, bronchial epithelium, adventitia submucosa, pleura
and blood vessel endothelium) was examined, but no sig-
nificant differences were found (data not shown).
Soluble CEACAMs are present in human airways
Next, the presence of soluble CEACAM1, CEACAM5
and CEACAM6 in bronchoalveolar lavage fluid (BALF)
was evaluated. Therefore BALF samples were examined
by ELISA (Figure 2A). CEACAM1 was found with an
average concentration of 10 ng/ml (± 9 ng/ml SD) in 4
out of 181 BALF samples (2.2%). CEACAM5 was present
in 78.5% of BALF samples with an average concentration
of 11 ng/ml (± 13.6 ng/ml SD) and CEACAM6 in allc conditions in human lung
Smokers Hypertension
+ - + -
0.81) 1.00 (0.63) 0.72 (0.83) 0.70 (0.67) 1.00 (0.87)
0.60) 1.50 (0.84) 1.62 (0.77) 1.80 (0.63) 1.33 (0.87)
0.50) 2.50 (0.55) 2.59 (0.51) 2.60 (0.52) 2.56 (0.53)
0 0.07 (0.28) 0 0.11 (0.33)
0.30) 0.17 (0.41) 0.10 (0.38) 0.20 (0.42) 0.11 (0.33)
nts (N=19) were stained for CEACAM1, CEACAM5, CEACAM6, CEACAM8 and an
elative total stainings (including alveolar epithelium, bronchial epithelium,
range of 0 (no staining) to 3 (strong staining). Numbers given are mean




























Figure 2 Soluble CEACAMs in bronchoalveolar lavage fluid and
NHBE cells. (A) Bronchoalveolar lavage fluid from 181 donors was
tested for presence of soluble CEACAM1, CEACAM5 and CEACAM6
by colorimetric sandwich ELISA using specific antibodies. The
diagram shows mean CEACAM concentrations (ng/ml) and standard
error of positive samples (CEACAM1=4, CEACAM5=142 and
CEACAM6=181 positive samples; logarythmic scale; SD in the Results
text). Percentages below columns give percent of BALF samples
positive for the respective CEACAM. (B) Confluent NHBE cells were
tested for the expression of soluble CEACAM1 isoforms CEACAM1-4C1,
CEACAM1-3 and CEACAM1-3C2 by RT-PCR. HPRT1 mRNA expression is
shown as control housekeeping gene. (C) NHBE cell culture
supernatants were tested for the presence of soluble CEACAM1
(approx. 110 kDa), CEACAM6 (approx. 90 kDa) and CEACAM5
(approx. 180 kDa) by immunoprecipitation with specific monoclonal
antibodies (B3-17, 2H8-5, and 13H10) or an IgG1 isotype control and
subsequent Western blot analysis with polyclonal anti-CEACAM5
antibody that cross-reacts with all three CEACAMs.
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ml (± 48 ng/ml SD).
In order to approach soluble CEACAM1 expression
in human lung with an alternative method, normal
human bronchial epithelial (NHBE) cells from healthy
donors were used for transcription analysis. RT-PCR
and subsequent sequencing of the obtained PCR-
products confirmed the expression of three soluble
CEACAM1 isoforms, CEACAM1-4C1, CEACAM1-3
and CEACAM1-3C2 (Figure 2B). However, mRNAs of all
three isoforms were not expressed at sufficient levels to
allow for reliable quantification analysis by qPCR. To test
for expressed and shedded soluble CEACAMs in NHBE
cells, CEACAM1-, 5-, and 6- immunoprecipitations from
cell culture supernatants were analyzed. Western blot ana-
lysis revealed soluble CEACAM6 and low amounts of sol-
uble CEACAM1, but no soluble CEACAM5 (Figure 2C)
in NHBE cell culture supernatants.
CEACAM1 isoforms are up-regulated by interferons and
TLR3 agonist poly I:C
In order to investigate the regulation of CEACAMs by
cigarette smoke or in the presence of acute inflammation
in human lung, NHBE cells were stimulated as described
below and the expression of CEACAMs was analyzed
using RT-PCR and qPCR. Untreated confluent NHBE
cells expressed CEACAM5 and CEACAM6, as well as
the CEACAM1 isoforms CEACAM1-4L, CEACAM1-4S,
CEACAM1-3L and CEACAM1-3S. This was shown
through RT-PCR analysis with pairs of primers specific
for each CEACAM and isoforms (Table 5). Identity of
the obtained PCR-products for each CEACAM and
isoforms was confirmed by sequencing. The intensity of
the resulting bands after electrophoretic separation sug-
gests that both CEACAM1 isoforms bearing the long
cytoplasmic domain were expressed to a much lesser ex-
tent than the two short CEACAM1 isoforms. To address
short-term effects of smoking on epithelial CEACAM
expression, NHBE cells were exposed to CSE. To assess
the tie of CEACAM expression in human lung cells to
innate immune responses, NHBE cells were treated with
IFNα, IFNβ, IFNγ, TNFα, and the TLR agonists MALP-2
(TLR2/6), poly I:C (TLR3) and flagellin (TLR5). Then,
RNA from these cells was isolated and qPCR analysis
was used to check for differences in CEACAM1-4L,
CEACAM1-3L, CEACAM1-4S, CEACAM1-3S, CEACAM5
and CEACAM6 mRNA levels. To ensure an accurate
normalization of their expression levels, we tested two
candidate housekeeping genes for their stability across
the unstimulated and stimulated samples. PPIB (SD
(±Ct)=0.24; CV(%Ct)=1.24) as well as HPRT1 (SD(±Ct)=
0.34; CV(%Ct)=1.42) showed a highly stable expression,
allowing for normalization with the geometric means of
both genes.
Table 5 Primers (RT-PCR and qPCR)
Gene/variant Symbol Forward Primer Reverse primer Size (bp)
CEACAM1-4L AAGACGATCATAGTCACTGAGCT GGAGACTGAGGGTTTGTGCT 483
CEACAM1-4S AAGACGATCATAGTCACTGAGCT ATTGGAGTGGTCCTGAGCTG 454
CEACAM1-3L TCATAGTCACTGATAATGCTCTACC GGAGACTGAGGGTTTGTGCT 188
CEACAM1-3S TCATAGTCACTGATAATGCTCTACC ATTGGAGTGGTCCTGAGCTG 159
CEACAM1-4C1 AAGACGATCATAGTCACTGAGCT TTGCACACCATTGACAGAGT 369
CEACAM1-3 CAGTGACCCAGTCACCTTGA TGGACTTGTTTGTGCCTGTTG 403
CEACAM1-3C2 CAAGACGATCATAGTCACTGAGTC AGAGGGACATATAGGAAGGGGT 210
CEACAM5 AGGCCAATAACTCAGCCAGT GGGTTTGGAGTTGTTGCTGG 104
CEACAM6 TCAGCCACTGGCCTCAATAG TCTGGTCCAATCTGCCAGTC 177
HPRT1 GACCAGTCAACAGGGGACAT AACACTTCGTGGGGTCCTTTTC 195
PPIB ATGTAGGCCGGGTGATCTTT TGAAGTTCTCATCGGGGAAG 219
IFNβ-1a TGCTCTCCTGTTGTGCTTCT CCACAGGAGCTTCTGACACT 103
Structure of forward and reverse primers (5′-3′) of all target genes and isoforms and the expected size of their respective amplified PCR-products.
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4L, CEACAM1-3L, CEACAM1-4S and CEACAM1-3S
were basically co-regulated by all reagents that elicited a
difference in transcription levels (Table 5, Figure 3B). IFNα
significantly upregulated the expression of CEACAM1-4L
(3.7-fold, p < 0.05), CEACAM1-4S (4.8-fold, p < 0.05) and
CEACAM1-3S (4.3-fold, p < 0.001), whereas the 3.5-fold
upregulation of CEACAM1-3L failed to reach significance
(p = 0.124). IFNβ and IFNγ significantly increased the
expression of all four splicing variants of CEACAM1
(p < 0.05 in all cases). In the case of IFNβ we could ob-
serve a slightly higher up-regulation of the two short
isoforms CEACAM1-4S (5.2-fold) and CEACAM1-3S
(4.7-fold) than the long isoforms CEACAM1-4L (4.4-fold)
and CEACAM1-3L (3.0-fold). On the other side, IFNγ
seemed to favor the two long isoforms CEACAM1-4L
(6.3-fold) and CEACAM1-3L (5.2-fold) when compared
to the short variants CEACAM1-4S (4.2-fold) and
CEACAM1-3S (3.5-fold). However, no significant alter-
ation in the ratios between long and short CEACAM1
isoforms was observed. Poly I:C treatment also up-
regulated all four isoforms of CEACAM1 in a significant
manner (p < 0.001 in all cases) with expression ratios ran-
ging between 4.9 and 7.0-fold (Figure 3B). CSE, TNFα,
MALP-2 and flagellin had no effect on any of the four
CEACAM1 transcripts despite of a significant increase of
the IL-8 mRNA levels, which served as positive control of
their efficacy (data not shown).
In order to examine whether the positive responses of
the CEACAM1 isoforms to poly I:C were caused by the
up-regulation of interferons, poly I:C treated NHBE cells
were analyzed for IFNα, IFNβ and IFNγ mRNA expres-
sion. IFNα and IFNγ mRNAs were not expressed at suffi-
cient levels to allow qPCR analysis (data not shown).
However, qPCR showed that poly I:C strongly induced animmediate IFNβ expression (780-fold increase after 4 h)
that dissolved after 24 h (Figure 3E). qPCR showed that
IFNγ treatment also significantly increased CEACAM5
mRNA levels in NHBE cells by 4.1-fold (Figure 3C). No
difference in CEACAM5 mRNA levels were induced by
CSE, IFNα, IFNβ, TNFα, or any of the TLR agonists.
CEACAM6 expression levels in NHBE cells were not al-
tered under any of the tested conditions (Figure 3D).
Increased CEACAM1 and CEACAM5 mRNA levels lead to
increased protein levels on NHBE cell surfaces
Indirect immunofluorescence showed that CEACAM1,
CEACAM5 and CEACAM6 were expressed on the cell
surface of untreated confluent NHBE cells (Figure 4A).
While CEACAM1 showed a low expression on most
cells, CEACAM5 and CEACAM6, respectively, were
only expressed by a subpopulation.
It was then tested whether the up-regulation of
CEACAM1 transcripts upon treatment with IFNα, IFNβ,
IFNγ, and poly I:C were also reflected by higher cell
surface protein levels. FACS analysis confirmed an in-
creased expression of CEACAM1 on the cell surface of
NHBE cells under all four conditions (Figure 4B). The
CEACAM1-specific antibody used for flow cytometry did
not allow discrimination between the different isoforms.
Also, an increased CEACAM5 cell surface expression
upon IFNγ treatment could be confirmed by FACS ana-
lysis (Figure 4C). Flow cytometry also verified that there
was only a small subpopulation of NHBE cells that were
CEACAM5 positive in untreated control cells. Upon
IFNγ treatment, both, the number of CEACAM5-
positive cells and the expression level of CEACAM5 on
the cell surface, were increased (Figure 4C). However, it




















































































































































































































Figure 3 Regulation of CEACAM expression by CSE, cytokines, and TLR agonists. (A) Confluent NHBE cells were tested for the expression of
CEACAM1-4L, CEACAM1-3L, CEACAM1-4S, CEACAM1-3S, CEACAM5, CEACAM6 and the house-keeping gene HPRT1 by RT-PCR using the primers
listed in Table 5. (B, D, E) Confluent NHBE cells were incubated with IFNα, IFNβ, IFNγ, TNFα, MALP-2, poly I:C, flagellin, or CSE, respectively, for
24 h. Real time qPCR was then used to analyze these cells for CEACAM1-4L, CEACAM1-4S, CEACAM1-3L and CEACAM1-3S mRNA expression
(B), CEACAM5 mRNA expression (C) or CEACAM6 mRNA expression (D), respectively. (E) Confluent NHBE cells were incubated with poly I:C for 4,
8 and 24 h and were tested by qPCR for IFNβ mRNA expression. (B-E) The mRNA expression of each transcript was normalized against two
housekeeping genes. Expression ratios relative to unstimulated cells were calculated using REST2009 and are represented by box-whisker plots.
Dashed lines represent the median expression; boxes and whiskers represent the interquartile range and the maximum and minimum
observation, respectively. *P < 0.05, #P = 0.124.
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catarrhalis up-regulate CEACAM1 expression
Next, the effects of acute NTHi and Moraxella catarrhalis
infection on CEACAM1, CEACAM5 and CEACAM6
mRNA expression levels in NHBE cells were investigated
(Figure 5). qPCR analysis revealed no differences in
CEACAM5 and CEACAM6 expression upon bacterial in-
fection. The M. catarrhalis wild type strains 25238 and
BBH18 as well as the NTHi wild type strains 2019 and
1128 enhanced the mRNA expression of all four trans-
membrane CEACAM1-isoforms to a similar degree in a
co-regulatory manner (Figure 5A,B,D,E). The mean induc-
tion of CEACAM1 transcription by M. catarrhalis strains
was twice as high as by NTHi strains (3.5-5.5 fold vs. 1.9-
2.8 fold). Since all four pathogens can bind to CEACAM1,
we next tested whether this interaction was essential tothe up-regulation of CEACAM1. To that end we used the
M. catarrhalis UspA deletion mutant BBH18.1 and the
NTHi P5 deletion mutant 1128f-, which both lack the re-
spective CEACAM1-binding adhesin (Figure 5C,F). Again,
the infection with these strains induced an elevated
CEACAM1 expression (4.0-4.9 fold and 1.9-2.4 fold, re-
spectively) comparable to their parental strains, indicating
a CEACAM1-independent, more general mechanism for
this effect. We then tested whether the CEACAM1 up-
regulation might be due to an increase in interferons. Both
M. catarrhalis 25238 and NTHi 2019 induced only a very
small increase in IFNβ mRNA levels in NHBE cells that in
part were not significant (Figure 5C). IFNβ mRNA levels
were elevated two-fold or less after 4 and 8 h by both
pathogens (compared to the 780-fold increase by poly







































Figure 4 (See legend on next page.)
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(See figure on previous page.)
Figure 4 Cell surface expression of CEACAM1, CEACAM5 and CEACAM6 in NHBE cells. (A) Confocal images of indirect immunofluorescences of
CEACAM1, CEACAM5 and CEACAM6 in non-permeabilized NHBE cells using mono-specific antibodies. Actin was detected using TRIC-conjugated
phalloidin and nuclei were stained with Hoechst33342. Merged images display pseudo-colors; green: CEACAMs, red: actin, blue: chromatin. (B) FACS
analysis of CEACAM1 expression on NHBE cell surfaces. Confluent NHBE cells were left untreated or incubated for 24 h with polyI:C, IFNα, IFNβ or IFNγ,
respectively, and subjected to FACS analysis. Data are representative of three experiments with similar results. Filled histograms: IgG control, open
histograms: CEACAM1. Numbers give mean intensity (arbitrary units). Mean IgG control = 62. (C) FACS analysis of CEACAM5 expression on NHBE cell
surfaces. Confluent NHBE cells were left untreated or incubated with IFNγ for 24 h and subjected to FACS analysis. Data are representative of three
experiments with similar results. Filled histograms: IgG control, open histograms: CEACAM5. Numbers give mean intensity (arbitrary units). Mean IgG
control = 51.
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after 24 h.
Discussion
Here we present the first comprehensive study based on
immunohistochemistry demonstrating that CEACAM1,
CEACAM5, and CEACAM6 are frequently co-expressed
in several tissues of the human lung, including epithelia
of the airways and alveoli. CEACAM expression was not
connected to COPD, smoking status and granulocyte in-
filtration (Figure 1, Tables 3 and 4). Despite the analysis
of non-cancer tissues from the specimen, the fact that
the lung sections used for immunohistochemical analysis
were from patients that underwent lung resection to
treat lung cancer might conceal a regulatory effect of
COPD or smoking status on CEACAM expression, since
CEACAM1, CEACAM5, and CEACAM6 have all been
shown to be up-regulated in lung cancer [49-53]. Also,
the inflammatory processes associated with cancers of
the lung might have had an effect on the expression
levels of the CEACAMs. For example, as discussed
below, IFNγ can up-regulate CEACAMs 1, 5, and 6. Im-
portantly, we show that the COPD-associated pathogens
M. catarrhalis and NTHi can also upregulate CEACAM1
expression independent of their ability to bind to
CEACAM1.
The up-regulation by M. catarrhalis might be at least in
part due to the induction of IFNβ production (Figure 5G)
and is in accordance with the observation of CEACAM1
up-regulation by pathogenic Neisseria in endothelial and
epithelial cells [54,55]. CEACAM5 and CEACAM6 ex-
pression levels were not affected by M. catarrhalis and
NTHi. However, both receptors were already expressed at
high levels and in all specimens (Figure 1, Tables 2 and 3).
Regarding colonization, the increase in CEACAM1 on
epithelial cells upon bacterial challenge is likely to increase
bacterial adherence and infection. This interaction would
be facilitated by an impaired mucocilliary clearance, which
is associated with later phases of COPD. Thus, CEACAM
receptors might be at least in part responsible for the
colonization of the lower airways by M. catarrhalis and
NTHi in COPD patients. This setting would also explain
the association of bacterial colonization with progressive/
advanced disease despite the fact that we did not find aregulation of CEACAM expression by the chronic patho-
logic conditions COPD, smoking status and granulocyte
infiltration (Figure 1, Tables 3 and 4). Further studies in-
cluding identification of pathogens in the lower airways
will be necessary to shed light on this aspect of
CEACAM-pathogen interactions. It will be also important
to take into account that an up-regulation of CEACAMs
might be transient either due to temporary qualities of
chronic/persistent disease or due to pathogen characteris-
tics at distinct time points during the infection process. It
will also be interesting to test human lung tissues for the
presence of the other CEACAMs expressed on epithelial
cells (CEACAM7, 18, 20 and 21 [56,57]) and to analyze
their ability to interact with pathogens.
The up-regulation of membrane-bound CEACAM re-
ceptors might be necessary to counteract the presence of
soluble receptor forms that might act as decoys to pre-
vent bacterial/viral infections or immune evasion. Even
though bacteria possess redundant targeting mecha-
nisms, and bacterial adhesins often work in a sequential
manner, Hill et al. showed that perturbing CEACAM1-,
CEACAM5- and CEACAM6-based adhesion by using a
CEACAM-binding peptide prevents host cell binding by
M. catarrhalis, H. influenzae, N. meningitidis and N.
gonorrhoeae in a cell culture model [7]. The amounts of
soluble CEACAMs, with high concentrations of soluble
CEACAM6 in all and lower concentrations of soluble
CEACAM5 in 78.5% of the bronchoalveolar lavage fluid
samples is mirrored in the expression levels of their
membrane-bound counterparts in lung tissues (Figures 1,
2, 3, 4 and [58-60]). The fact that soluble CEACAM1 is
all but absent in BALF (98% negative BALF samples) in-
creases the importance of this receptor for colonization
by pathogens despite its comparatively low expression
levels in human lung.
In NHBE cells, CEACAM1 mRNA and protein levels
were also increased by IFNα, IFNβ, IFNγ and the TLR3
agonist poly I:C (Figure 3B). All membrane-bound
CEACAM1 isoforms examined here were basically co-
regulated under all conditions that affected their expres-
sion level (Figures 3 and 5). However, some differences
were found for the differential up-regulation of the
CEACAM1 isoforms. Type I interferons (IFNα and






















































































































































































































































































Figure 5 Regulation of CEACAM expression by M. catarrhalis and non-typable H. influenzae (NTHi). Confluent NHBE cells were incubated
with M. catarrhalis strains 25238 (wild type, A), BBH18 (wild type, B), BBH18.1 (UspA1 deletion mutant unable to bind CEACAM1, C), or NTHi strains
2019 (wild type, D), 1128 (wild type, E), 1128f- (P5 deletion mutant unable to bind to CEACAM1, F) for 24 h. Cells were then subjected to qPCR analysis
of CEACAM1-4L, CEACAM1-3L, CEACAM1-4S, CEACAM1-3S, CEACAM5, and CEACAM6 mRNA expression. (G) Confluent NHBE cells were incubated with
M. catarrhalis strain 25238 or NTHi strain 2019 for 4 h, 8 h or 24 h and subjected to qPCR analysis for IFNβ mRNA expression.
(A-G) Distrubution of the normalized expression ratios are represented by box-whiskers plots. Dashed lines represent the median expression; boxes
and whiskers represent the interquartile range and the maximum and minimum observation, respectively. *P < 0.05, # P = 0.088, §P = 0.079.
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favored the long and the short isoforms bearing 4 extra-
cellular domains. Especially the former differences, even
though not significant, are interesting with regard to the
fact that in order to interfere with TLR signaling or with
T-cell activation, binding of the Shp-1 phosphatase to
the immunoreceptor tyrosine-based inhibitory motif(ITIM) within the cytoplasmic domain of the long
CEACAM1 isoform was necessary [15,16,19]. The two
tyrosine residues that are part of the ITIM can bind to
protein tyrosine kinases (e.g. c-Src) as well as protein
tyrosine phosphatases (e.g. Shp-2) - leading to the stimu-
lation or the inhibition of cell-signaling pathways, respec-
tively. Long and short CEACAM1 isoforms can appear as
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membrane [26,28]. Trans-homophilic binding between
different CEACAM1 molecules increases cis-dimerization
in the plane of the membrane via an allostery-based mech-
anism. Binding of CEACAM1-L to Shp-1 or c-Src is
dependent on the balance between the oligomeric states
as well as the ratio of long and short isoforms [26,28].
Interestingly, no cytoplasmic domain is necessary for the
CEACAM1-mediated internalization of H. influenzae, M.
catarrhalis and N. gonorrhea [27]. But bacterial engage-
ment of CEACAM1 might, in addition to procuring adher-
ence, also influence the cis-dimerization and subsequent
inhibitory or activatory signaling of CEACAM1, either
supporting pathogen colonization or host response. For
example, the interaction of CEACAM1 with M. catarrhalis
and N. meningitidis proteins resulted in reduced Toll-
like receptor (TLR) 2-initiated inflammatory responses
(the major mediator of M. catarrhalis-induced immune
responses) of NHBE cells [16,61,62].
Part of the host response to microbial infection is the
production of cytokines [63]. Type I interferons IFNα
and IFNβ can be produced by most cell types and are
the major effector cytokines of the host immune re-
sponse against viral infections. However, the production
of type I interferons is also induced in response to bac-
terial infections [64]. The type II interferon IFNγ plays
an important role during the immune response to bac-
terial pathogens, but is also induced upon infection with
viruses. It is produced predominantly by natural killer
(NK) cells and natural killer T cells as part of the innate
immune response and by Th1 CD4+ and CD8+ cytotoxic
T lymphocyte effector T cells once antigen-specific im-
munity develops [65]. In the present study CEACAM5 is
up-regulated in NHBE cells by IFNγ, but not by type I in-
terferons, and CEACAM1 is increased by type I and type
II interferons (IFNβ and IFNγ, Figure 3B and D). While
for CEACAM1, CEACAM5 and CEACAM6 an up-
regulation by IFNγ and viral infections has been described
in epithelial cells [55,66-70], to our knowledge this is the
first report that also type I interferons enhance CEACAM1
expression.
A temporal association between bacterial and viral
infections is often observed in the human upper res-
piratory tract [71,72]. Infection by opportunistic colo-
nizers, including Haemophilus influenzae and Moraxella
catarrhalis, increases considerably following influenza and/
or respiratory syncytial virus (RSV) infections [71,72].
COPD is often associated with viral infections, mostly by
rhinovirus, and it was recently shown that these infections
indeed precipitate secondary bacterial infections, particu-
larly in COPD patients [73].
Importantly, the present study shows that in addition
to the primarily viral induced type I interferons, TLR3
agonist poly I:C also increased CEACAM1 expression(Figure 3B). TLR3 plays a key role in anti-viral immune
responses and recognizes synthetic dsRNA like poly I:C
and virus derived dsRNA contained in cells infected by
positive-stranded RNA viruses and DNA viruses [74,75].
It was shown recently that poly I:C enhances the suscepti-
bility to secondary pulmonary infections by gram-positive
bacteria in a mouse model [76]. The positive-stranded
RNA virus rhinovirus enhances CEACAM5 expression in
human nasal epithelial cells and two negative-stranded
RNA viruses, respiratory syncytial virus (RSV) and human
parainfluenza virus 3 (HPIV-3), enhance CEACAM1 ex-
pression in A549 and NHBE cells [67,77]. Since the latter
viruses have to be recognized via TLR7 or TLR8, this is
the first indication that the pathogen receptor CEACAM1
might also be up-regulated by positive-stranded RNA
viruses via TLR3.
CEACAM6 expression was not altered by any agent
used in this investigation (Figure 3D). This was probably
due to its initially high expression level in the NHBE
cells. Fahlgren et al. showed that the LS174T cell line
that expressed high levels of CEACAM5 and CEACAM6
before IFNγ treatment did not show any enhanced ex-
pression after IFNγ exposure while IFNγ up-regulated
both mRNAs in two cell lines, HT-29 and T84, that ini-
tially expressed low levels of CEACAM5 and CEACAM6
[66]. However, the very high and constant CEACAM6
expression in NHBE cells as well as in the lung speci-
mens is in accordance with its proposed role as a surfac-
tant [58,78].
The up-regulation via viruses and the effects of the in-
flammatory cytokine IFNγ imply a more general role for
CEACAM1 and CEACAM5 in the inflammatory re-
sponse to infection, and also in the spatial and temporal
association between bacterial and viral infections. One
of the underlying mechanisms for the colonization of
COPD patients by M. catarrhalis and NTHi may consist
of the up-regulation of specific host receptors, i.e.
CEACAM1, by viral infections, as described for several
CEA family receptors [55,66,68,77]. For pathogenic
Neisseria it was demonstrated that increased CEACAM
expression levels correlated with an increase in bacterial
invasion [55,79]. Once established, M. catarrhalis and
NTHi themselves are also able to increase the expres-
sion of their receptor CEACAM1. Whether the starting
point is a viral or bacterial pathogen, the result is a con-
tinual cycle of infection-induced increase in cytokine
levels and, subsequently, receptor expression which then
promotes bacterial invasion. Since viruses also recruit
CEACAMs, elevated CEACAM expression might aid
viral infection as well [80,81].
Conclusions
CEACAM1 is a well-established receptor for bacteria,
including the human pathogens M. catarrhalis and H.
Klaile et al. Respiratory Research 2013, 14:85 Page 15 of 17
http://respiratory-research.com/content/14/1/85influenza that both colonize about one third of all COPD
patients and cause acute exacerbations. While we did not
find a direct correlation between CEACAM expression
and COPD, these COPD-linked bacteria were able to in-
crease the expression of their own receptor on host cells.
We also propose a role for the constitutively expressed
CEACAM6 as well as CEACAM1 and CEACAM5 in the
phenomenon of increased host susceptibility to bacterial
infection upon viral challenge in the human respiratory
tract, as it occours for example in COPD patients, since
either enhanced CEACAM1 expression induced by viruses
or the COPD-associated changes in the function of the
mucociliary clearance that will allow an easy access to
CEACAMs on respiratory epithelia are likely to increase
bacterial colonization.
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